• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Age-related changes in growth hormone releasing factor and somatostatin in the rat hypothalamus.

作者信息

Morimoto N, Kawakami F, Makino S, Chihara K, Hasegawa M, Ibata Y

机构信息

Department of Anatomy, Kyoto Prefectural University of Medicine, Japan.

出版信息

Neuroendocrinology. 1988 May;47(5):459-64. doi: 10.1159/000124950.

DOI:10.1159/000124950
PMID:2899847
Abstract

Distribution and staining intensities of growth hormone releasing factor (GR (GRF) and somatostatin (SRIF) were examined in young (3 months of age) and old (24 months of age) male rats of Sprague-Dawley strain, using the PAP immunocytochemical procedure. Some animals of each age group were intraventricularly injected with colchicine to demonstrate immunoreactive neuronal perikarya. GRF-immunoreactive intensities of old rats were markedly reduced in the median eminence as compared with those of young rats. No remarkable difference could be detected between SRIF immunoreactivities in the young and old animals, since intensive SRIF immunoreactivities were found in the external layer of the median eminence of both groups of animals. Between two age groups injected with colchicine, we also found no difference in the distribution and staining intensities of immunoreactive perikarya of GRF and SRIF in the hypothalamus and also detected no significant difference in total neuron numbers of each peptide. These findings suggest that the synthesis and/or release of GRF in GRF-containing neurons are decreased, though GRF-containing neurons themselves remain alive and have the capacity to synthesize GRF.

摘要

相似文献

1
Age-related changes in growth hormone releasing factor and somatostatin in the rat hypothalamus.
Neuroendocrinology. 1988 May;47(5):459-64. doi: 10.1159/000124950.
2
Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.半胱胺诱导弓状核神经元中生长激素释放因子(GRF)免疫反应性增强:下丘脑内假定的生长抑素/GRF相互作用的形态学证据。
Endocrinology. 1990 Nov;127(5):2551-60. doi: 10.1210/endo-127-5-2551.
3
Evidence for direct action of estradiol on growth hormone-releasing factor (GRF) in rat hypothalamus: localization of [3H]estradiol in GRF neurons.雌二醇对大鼠下丘脑生长激素释放因子(GRF)直接作用的证据:[3H]雌二醇在GRF神经元中的定位。
Endocrinology. 1990 Jul;127(1):344-9. doi: 10.1210/endo-127-1-344.
4
Hypothalamic interconnections of somatostatin and growth hormone releasing factor neurons.生长抑素和生长激素释放因子神经元的下丘脑相互联系。
Neuroendocrinology. 1989 Nov;50(5):584-91. doi: 10.1159/000125285.
5
Immunohistochemical studies on the somatostatin- and growth hormone-releasing factor (GRF)-neurons in the hypothalamus of the novel dwarf rat; the spontaneous dwarf rat (dr).新型侏儒大鼠(自发侏儒大鼠,dr)下丘脑生长抑素和生长激素释放因子(GRF)神经元的免疫组织化学研究。
Brain Res. 1989 Jul 31;493(2):402-6. doi: 10.1016/0006-8993(89)91179-7.
6
Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.链脲佐菌素诱导的糖尿病大鼠垂体生长激素(GH)调节异常:下丘脑生长抑素和生长激素释放因子的联合缺陷
Endocrinology. 1990 Jan;126(1):53-61. doi: 10.1210/endo-126-1-53.
7
Colocalization of somatostatin receptors and growth hormone-releasing factor immunoreactivity in neurons of the rat arcuate nucleus.大鼠弓状核神经元中生长抑素受体与生长激素释放因子免疫反应性的共定位
Neuroendocrinology. 1992 Jul;56(1):18-24. doi: 10.1159/000126203.
8
Ontogeny of growth hormone-releasing factor in the rat hypothalamus.大鼠下丘脑生长激素释放因子的个体发生
Neuroendocrinology. 1986;44(1):59-64. doi: 10.1159/000124622.
9
A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.下丘脑生长抑素在维持大鼠垂体对生长激素释放因子反应性中的可能作用。
Endocrinology. 1990 Jan;126(1):285-91. doi: 10.1210/endo-126-1-285.
10
Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels.胰岛素样生长因子I通过生长激素释放因子调节下丘脑生长抑素,增加生长抑素释放及信使核糖核酸水平。
Brain Res. 1993 Oct 22;625(2):213-8. doi: 10.1016/0006-8993(93)91061-v.

引用本文的文献

1
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction.靶向细胞衰老和衰老细胞清除:与年龄相关的内分泌功能障碍的新干预措施。
Endocr Rev. 2024 Sep 12;45(5):655-675. doi: 10.1210/endrev/bnae010.
2
Age-Related Hormones Changes and Its Impact on Health Status and Lifespan.年龄相关的激素变化及其对健康状况和寿命的影响。
Aging Dis. 2023 Jun 1;14(3):605-620. doi: 10.14336/AD.2022.1109.
3
Dietary restriction maintains the basal rate of somatotrope renewal in later life in male rats.饮食限制可维持雄性大鼠晚年生长激素细胞的基础更新率。
Age (Omaha). 1997 Jul;20(3):169-74. doi: 10.1007/s11357-997-0016-y.
4
Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging.与年龄相关的神经内分泌控制变化,而非受体敏感性受损,导致了生长激素释放肽(GHRPs)在人类衰老过程中生长激素释放活性的降低。
Pituitary. 1998 Apr;1(1):51-8. doi: 10.1023/a:1009970909015.
5
Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration.口服后,精氨酸可增强合成六肽(GHRP - 6)在老年受试者中的生长激素释放活性,但在年轻受试者中则不然。
J Endocrinol Invest. 1994 Mar;17(3):157-62. doi: 10.1007/BF03347707.
6
Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects.低剂量静脉注射或口服精氨酸能够增强老年受试者对生长激素释放激素的生长激素反应。
J Endocrinol Invest. 1994 Feb;17(2):113-7. doi: 10.1007/BF03347695.
7
Immunocytochemical and immuno-electron-microscopical study of growth hormone cells in male and female rats of various ages.不同年龄雄性和雌性大鼠生长激素细胞的免疫细胞化学和免疫电子显微镜研究。
Cell Tissue Res. 1991 Nov;266(2):275-84. doi: 10.1007/BF00318183.
8
A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging.
J Endocrinol Invest. 1992 Oct;15(9):665-70. doi: 10.1007/BF03345812.